NASHVILLE, Tenn., April 24, 2018 -- Aegis Sciences Corporation, a leading healthcare sciences and forensic toxicology laboratory, is pleased to announce that Dr. Elaine Jeter has joined the company as its Senior Medical Policy Advisor.
“I am delighted to welcome Dr. Elaine Jeter,” said Dr. Frank Basile, Aegis’s Chief Executive Officer. “Dr. Jeter’s wealth of experience in clinical medicine and Medicare will be very valuable to Aegis.”
As Senior Medical Policy Advisor, Dr. Jeter will assist with both regulatory and medical coverage policy engagement and compliance, new and existing Managed Care relationships, and development of appropriate evidence-based clinical utility evidence for Aegis’s new and innovative testing services.
In regards to her decision to serve as Aegis’s Senior Medical Policy Advisor, Dr. Jeter said, “I am excited to join the Aegis team in this critical role as it has and continues to maintain a pristine track record for quality, compliance and integrity in toxicology testing, which is manifest at all levels within the organization.”
Prior to joining Aegis, Dr. Jeter was the Senior Medical Director at Palmetto GBA, a Medicare Administrative Contractor that administers Medicare health insurance for the Centers for Medicare & Medicaid Services (CMS) throughout the U.S. At Palmetto GBA, Dr. Jeter developed and directed the MolDX program, which was created to uniquely identify laboratory tests, primarily sole-source and molecular tests, and to determine the clinical value of a test by way of a technical assessment. The assessments were subsequently developed into Medicare local coverage decision policies. In the field of toxicology, her “Controlled Substance Monitoring and Drugs of Abuse Testing” coverage policy has largely become the model across the country for providers and payers alike.
Dr. Jeter has practiced surgical pathology and directed clinical laboratories in academia and the private practice. She completed her medical school and residency training at the Medical University of South Carolina (MUSC) in Charleston, SC. She is board certified in Anatomic and Clinical Pathology, with sub-specialty boards in Blood Banking and Transfusion Medicine.
About Aegis Sciences Corporation
Founded in 1990, Aegis Sciences Corporation is a laboratory sciences company based in Nashville, TN, that provides science-driven testing and consulting services for clients such as healthcare providers, pharmaceutical companies, professional and amateur sports organizations, leading college and university athletic programs, Fortune 500 corporations, and government agencies throughout the United States. For more information please visit http://www.aegislabs.com/
Contact:
Stephanie Protz, Manager, Marketing Communications
[email protected]
615-577-4535


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



